Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Phillips

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The International Journal of Neuropsychopharmacology|August 22, 2022
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic KetamineBartholt Bloomfield-Clagett, Elizabeth D Ballard, Deanna K Greenstein, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 19, 2021
Emerging New Psychiatric Symptoms and the Worsening of Pre-existing Mental Disorders during the COVID-19 Pandemic: A Canadian Multisite Study: Nouveaux symptômes psychiatriques émergents et détérioration des troubles mentaux préexistants durant la pandémie de la COVID-19: une étude canadienne multisiteRebecca Robillard, Alexander R Daros, Jennifer L Phillips, et al.
Research Square|June 10, 2024
Oligomeric amyloid beta prevents myelination in a clusterin-dependent mannerRebecca M Beiter, Tula P Raghavan, Olivia Suchocki, et al.
Heliyon|January 27, 2025
Clusterin induced by OPC phagocytosis blocks IL-9 secretion to inhibit myelination in a model of Alzheimer's diseaseRebecca M Beiter, Tula P Raghavan, Olivia Suchocki, et al.
Psychiatry and Clinical Psychopharmacology|August 29, 2025
Interventional Psychiatry and Emerging Treatments for Posttraumatic Stress Disorder (PTSD): A Systematic ReviewReinhard Janssen-Aguilar, Shakila Meshkat, Huda F Al-Shamali, et al.
BMC Psychiatry|June 4, 2020
A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocolJennifer L Phillips, Natalia Jaworska, Elizabeth Kamler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisCemal Akmese, Rodrigo Francisco Tomas, Huong T Phuong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisHuong T Phuong, Rodrigo Francisco Tomas, Cemal Akamese, et al.
British Journal of Haematology|April 1, 2015
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patientsAnders Österborg, William G Wierda, Jiří Mayer, et al.
Haematologica|March 15, 2015
Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal studyAnders Österborg, Roxanne C Jewell, Swami Padmanabhan-Iyer, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The International Journal of Neuropsychopharmacology|August 22, 2022
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic KetamineBartholt Bloomfield-Clagett, Elizabeth D Ballard, Deanna K Greenstein, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|January 19, 2021
Emerging New Psychiatric Symptoms and the Worsening of Pre-existing Mental Disorders during the COVID-19 Pandemic: A Canadian Multisite Study: Nouveaux symptômes psychiatriques émergents et détérioration des troubles mentaux préexistants durant la pandémie de la COVID-19: une étude canadienne multisiteRebecca Robillard, Alexander R Daros, Jennifer L Phillips, et al.
Research Square|June 10, 2024
Oligomeric amyloid beta prevents myelination in a clusterin-dependent mannerRebecca M Beiter, Tula P Raghavan, Olivia Suchocki, et al.
Heliyon|January 27, 2025
Clusterin induced by OPC phagocytosis blocks IL-9 secretion to inhibit myelination in a model of Alzheimer's diseaseRebecca M Beiter, Tula P Raghavan, Olivia Suchocki, et al.
Psychiatry and Clinical Psychopharmacology|August 29, 2025
Interventional Psychiatry and Emerging Treatments for Posttraumatic Stress Disorder (PTSD): A Systematic ReviewReinhard Janssen-Aguilar, Shakila Meshkat, Huda F Al-Shamali, et al.
BMC Psychiatry|June 4, 2020
A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocolJennifer L Phillips, Natalia Jaworska, Elizabeth Kamler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisCemal Akmese, Rodrigo Francisco Tomas, Huong T Phuong, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisHuong T Phuong, Rodrigo Francisco Tomas, Cemal Akamese, et al.
British Journal of Haematology|April 1, 2015
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patientsAnders Österborg, William G Wierda, Jiří Mayer, et al.
Haematologica|March 15, 2015
Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal studyAnders Österborg, Roxanne C Jewell, Swami Padmanabhan-Iyer, et al.
Pageof 5